Brookstone Capital Management Albemarle Corp Transaction History

Brookstone Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	BUY	$172.91 - $232.22 $258,327 - $346,936	1,494 Added 124.09%	2,698 $601,000
Q1 2023 Apr 18, 2023	SELL	$208.49 - $290.15 $117,796 - $163,934	-565 Reduced 31.94%	1,204 $266,000
Q4 2022 Jan 09, 2023	SELL	$214.02 - $325.38 $362,977 - $551,844	-1,696 Reduced 48.95%	1,769 $0
Q3 2022 Oct 13, 2022	BUY	$195.82 - $307.05 $678,516 - $1.06 Million	3,465 New	3,465 $871,000
Q4 2021 Jan 11, 2022	SELL	$214.16 - $283.8 $569,879 - $755,191	-2,661 Closed	0 $0
Q3 2021 Nov 03, 2021	BUY	$167.91 - $244.03 $446,808 - $649,363	2,661 New	2,661 $595,000
Q1 2021 Apr 16, 2021	SELL	$140.69 - $185.25 $210,753 - $277,504	-1,498 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$86.73 - $149.91 $129,921 - $224,565	1,498 New	1,498 $221,000

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brookstone Capital Management with notifications on news.